Aldesleukin Recruiting Phase 2 Trials for Type1 Diabetes Treatment

IndicationsStatusPurposePhase
RecruitingTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT03782636Interleukin-2 Therapy of Autoimmunity in Diabetes (ITAD)